Press releases

À l’Inserm, la lutte contre la pandémie de Covid-19 se poursuit

Pour faire face à la pandémie de Covid-19, mieux comprendre le virus et accompagner la prise en charge des maladies, les scientifiques de l'Inserm sont plus que jamais mobilisés. ...
Press file | 25 Jan 2021 | Covid-19 Europe Institutional and special event Public health

Published Now in the New England Journal of Medicine: The Initial Results of the Solidarity/Discovery Clinical Trial

Back at the start of the pandemic, Inserm, through its REACTing consortium, set up Discovery: a European clinical trial to evaluate the efficacy of four antiviral drugs repurposed for the treatment of patients hospitalized with COVID-19 (remdesivir, hydroxychloroquine, lopinavir and interferon beta-1a). ...
Press release | 04 Dec 2020 | Covid-19 Europe Immunology, inflammation, infectiology and microbiology Public health

Cancer : un mécanisme clé de résistance à l’immunothérapie identifié

Une équipe internationale vient de publier dans la revue Immunity une étude qui ouvre des perspectives pour améliorer l’efficacité de l’immunothérapie. ...
Press release | 03 Dec 2020 | Cancer

A Disruption of the Microbiota Is Linked to the Formation of a Molecule Promoting Type 2 Diabetes

An imbalanced diet has been linked to a disruption of the gut microbiota, which promotes metabolic diseases such as diabetes. Researchers have shown, in a large European cohort, that changes in the composition of the gut microbiota lead to increased blood levels ...
Press release | 03 Dec 2020 | Circulation, metabolism, nutrition

Trois premiers essais cliniques vaccinaux prévus à partir du mois de décembre via la plateforme COVIREIVAC de l’Inserm

La France, forte de l’excellence de sa recherche clinique en matière de vaccination s’est organisée pour contribuer à l’évaluation des candidats vaccins contre la Covid-19 les plus prometteurs via la plateforme COVIREIVAC de l’Inserm. Trois essais cliniques vaccinaux devraient démarrer en France ...
Press release | 02 Dec 2020 | Covid-19 Immunology, inflammation, infectiology and microbiology Institutional and special event

Deciphering the energetic code of cells for better anticancer therapies

A procedure that may help personalise anticancer therapies has just been developed by the CNRS, Inserm, and Aix-Marseille University scientists at the Centre d’Immunologie de Marseille-Luminy, in association with colleagues from the University of California San Francisco and the Marseille Public University ...
Press release | 01 Dec 2020 | Immunology, inflammation, infectiology and microbiology

Neuroscience Provides New Ways to Understand the Origin of Our Emotions

Are our emotions innate or are they the product of our culture and environment? This question has long been the subject of debate in the field of neuroscience. Researchers provide robust clinical data in favor of the second hypothesis. Their work suggests ...
Press release | 01 Dec 2020 | Neurosciences, cognitives sciences, neurology and psychiatry
fermer
fermer
RSS Youtube